If you have Ambetter coverage and are considering GLP-1 treatment, understanding both insurance pathways and individual factors that influence medication response can support a more strategic conversation with your provider
On Saturday, February 7, reporting confirmed Hims stopped offering access to the compounded semaglutide pill after what it described as constructive conversations with stakeholders across the industry", in the wake of FDAs statements and the broader regulatory scrutiny
The remaining authors report no potential competing interests in this work
Semaglutide and Tirzepatide were initially developed to treat type 2 diabetes by regulating blood sugar
This is the first month Ive taken it, and Ive lost over 10 pounds this month (mind you Im exercising and eating healthy)
For people with Alzheimers and other neurodegenerative brain conditions, GLP-1s have shown mixed results